Materials Healthcare Sector

CARGO Therapeutics

Market Cap: US$187.2m

A clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients.

Quanterix

Market Cap: US$186.8m

A life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions.

Kodiak Sciences

Market Cap: US$186.0m

A clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases.

Y-mAbs Therapeutics

Market Cap: US$185.7m

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of radioimmunotherapy and antibody based therapeutic products for the treatment of cancer.

Pacific Smiles Group

Market Cap: AU$287.7m

Owns and operates dental centers under the Pacific Smiles Dental Centres and Nib Dental Care Centres names in Australia.

High Tide

Market Cap: CA$256.6m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Perspective Therapeutics

Market Cap: US$182.6m

Develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States.

Tonix Pharmaceuticals Holding

Market Cap: US$182.3m

A biopharmaceutical company, focuses on developing and commercializing therapeutics to treat and prevent human disease.

Omeros

Market Cap: US$182.2m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.

ProQR Therapeutics

Market Cap: US$181.2m

A biotechnology company, focuses on the discovery and development of novel therapeutic medicines.

Deltex Medical Group

Market Cap: US$180.6m

Manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, and internationally.

Organigram Global

Market Cap: CA$249.0m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

DiaMedica Therapeutics

Market Cap: US$177.0m

A clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases.

scPharmaceuticals

Market Cap: US$176.3m

A pharmaceutical company, focuses on developing and commercializing products to optimize the delivery of infused therapies and patient care.

TriSalus Life Sciences

Market Cap: US$175.6m

Engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers.

Stereotaxis

Market Cap: US$175.4m

Designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.

Baird Medical Investment Holdings

Market Cap: US$175.3m

Engages in research and development, manufacturing, and sales of microwave ablation and other medical devices in the People’s Republic of China.

Electromed

Market Cap: US$175.0m

Develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally.

OmniAb

Market Cap: US$174.9m

A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.

Voyager Therapeutics

Market Cap: US$174.3m

A biotechnology company, focuses on the human genetics for the cure of neurological diseases.

Utah Medical Products

Market Cap: US$173.2m

Provides medical devices for the healthcare industry worldwide.

INmune Bio

Market Cap: US$173.1m

A clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States.

Spectral Medical

Market Cap: CA$239.5m

Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.

AVITA Medical

Market Cap: US$172.4m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Esperion Therapeutics

Market Cap: US$169.1m

A pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States.

Anika Therapeutics

Market Cap: US$167.9m

A joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.

Sight Sciences

Market Cap: US$167.5m

An ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases.

AFT Pharmaceuticals

Market Cap: NZ$283.1m

Engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally.

Accuray

Market Cap: US$166.9m

Designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China.

Puma Biotechnology

Market Cap: US$166.3m

A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.

LENSAR

Market Cap: US$164.9m

A commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System.

4D Molecular Therapeutics

Market Cap: US$164.5m

A late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.

Procaps Group

Market Cap: US$163.6m

Develops, produces, and markets pharmaceutical solutions worldwide.

AC Immune

Market Cap: US$163.3m

A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.

CVRx

Market Cap: US$163.2m

A commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally.

EKF Diagnostics Holdings

Market Cap: UK£121.4m

Engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally.